Rich is currently a Principle Consultant and Chief Statistician with Pharmetheus. Prior to joining Pharmetheus Rich was Global Head of Statistics and Chief Statistician for Pfizer Inc. with responsibility for approximately 250 statisticians and a budget of $50M. In this role, he fostered a culture of collaboration across statisticians, clinical pharmacologists, and clinicians to enable and deliver Model Informed Drug Development (MIDD). Rich also led quantitative assessment of late stage probabilities of technical and regulatory success through modeling and simulation for all late-stage assets compared to industry/therapeutic area benchmarks and similarly assessed more than 50 potential external business development assets. As a member of cross PhRMA statistics group, he led collaborations delivering such things as Data Monitoring Committee member training.
Rich has over 25 years of drug development experience in Neuroscience, Pain, Cardiovascular, Infectious Disease, Rare Disease and holds an MS in Statistics from the University of Connecticut.